In the BioHarmony Drug Report Database

"Preview" Icon

Azathioprine

Imuran, Jayempi (azathioprine) is a small molecule pharmaceutical. Azathioprine was first approved as Imuran on 1982-01-01. It is used to treat crohn disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and thrombocytopenic purpura idiopathic amongst others in the USA. It has been approved in Europe to treat graft rejection. It is known to target C5a anaphylatoxin chemotactic receptor 1.

 

Trade Name

 

Jayempi
 

Common Name

 

azathioprine
 

ChEMBL ID

 

CHEMBL1542
 

Indication

 

crohn disease, graft rejection, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, thrombocytopenic purpura idiopathic, ulcerative colitis
 

Drug Class

 

Image (chem structure or protein)

Azathioprine structure rendering